论文部分内容阅读
目的观察米非司酮预防卵巢内异症囊肿术后复发的近期疗效。方法随访泰州市普济医院2009年1月至2012年3月收治的卵巢内异症囊肿患者65例。按术后是否用药分为用药组35例和未用药组30例;术后用药3~6个月;术后随访15~18个月,比较各组患者保守性手术后复发情况及疼痛症状改善情况。结果 165例患者中复发6例,复发率为9.23%,未用药组复发率为13.3%,用药组为2.9%,两组比较差异有统计学意义(P<0.05)。2痛经缓解及复发情况:用药组痛经缓解率为99.0%,复发率为2.9%;未用药组痛经缓解率为93.3%,复发率为13.3%。结论术后联合使用米非司酮,能很好地控制子宫内膜异位囊肿术后复发。
Objective To observe the short-term curative effect of mifepristone in preventing postoperative recurrence of ovarian endometriosis cysts. Methods Totally 65 cases of ovarian endometriosis cyst were admitted to Puji Hospital of Taizhou City from January 2009 to March 2012. The patients were divided into medication group (n = 35) and non-medication group (n = 30) after operation for 3 to 6 months. The patients were followed up for 15 to 18 months. The recurrence after conservative surgery and the improvement of pain symptom Happening. Results The recurrence rate was 9.23% in 165 patients, 13.3% in non - medication group and 2.9% in medication group. There was significant difference between the two groups (P <0.05). 2 Dysmenorrhea and remission of the situation: the treatment group dysmenorrhea remission rate was 99.0%, the recurrence rate was 2.9%; no medication group pain relief rate was 93.3%, the recurrence rate was 13.3%. Conclusion Postoperative combined use of mifepristone, can well control the recurrence of endometriotic cysts.